143 related articles for article (PubMed ID: 33360932)
1. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
3. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
Kim GR; Cho SN; Kim HS; Yu SY; Choi SY; Ryu Y; Lin MQ; Jin L; Kee HJ; Jeong MH
J Hypertens; 2016 Nov; 34(11):2206-19. PubMed ID: 27512969
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.
Choi SY; Kee HJ; Sun S; Seok YM; Ryu Y; Kim GR; Kee SJ; Pflieger M; Kurz T; Kassack MU; Jeong MH
J Cell Mol Med; 2019 Apr; 23(4):2801-2812. PubMed ID: 30734467
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
7. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
[TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species.
Kirabo A; Kearns PN; Jarajapu YP; Sasser JM; Oh SP; Grant MB; Kasahara H; Cardounel AJ; Baylis C; Wagner KU; Sayeski PP
Cardiovasc Res; 2011 Jul; 91(1):171-9. PubMed ID: 21354995
[TBL] [Abstract][Full Text] [Related]
9. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy.
Xu X; Ha CH; Wong C; Wang W; Hausser A; Pfizenmaier K; Olson EN; McKinsey TA; Jin ZG
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2355-62. PubMed ID: 17823368
[TBL] [Abstract][Full Text] [Related]
11. Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.
Ryu Y; Kee HJ; Sun S; Seok YM; Choi SY; Kim GR; Kee SJ; Pflieger M; Kurz T; Kim HS; Jeong MH
PLoS One; 2019; 14(3):e0213186. PubMed ID: 30830950
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
[TBL] [Abstract][Full Text] [Related]
13. NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.
Wang C; Luo Z; Carter G; Wellstein A; Jose PA; Tomlinson J; Leiper J; Welch WJ; Wilcox CS; Wang D
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R399-R406. PubMed ID: 29167164
[TBL] [Abstract][Full Text] [Related]
14. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
[TBL] [Abstract][Full Text] [Related]
16. HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression.
Hu T; Schreiter FC; Bagchi RA; Tatman PD; Hannink M; McKinsey TA
J Biol Chem; 2019 May; 294(21):8640-8652. PubMed ID: 30962285
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
[TBL] [Abstract][Full Text] [Related]
18. iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.
Calderon LE; Liu S; Su W; Xie Z; Guo Z; Eberhard W; Gong MC
PLoS One; 2012; 7(2):e31850. PubMed ID: 22363752
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
20. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
Kee HJ; Kim I; Jeong MH
Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
